Although current studies suggest that Cav-1 may regulate the progression of glomerular associated diseases by endocytosing of macromolecules (cholesterol or albumin), the mechanism by which Cav-1 modulates the development of glomerular diseases requires further study. This evidence concerns the gene CAV1 and glomerular disorder.